PorTal Access wins FDA clearance for FLEXI-PORT, but can a flexible chemo port change cancer care?
PorTal Access can begin commercialising its FLEXI-PORT implantable vascular access system for adults and children. Its flexible design, chest-or-arm placement options and smaller implantation profile could improve long-term infusion access, but clinical adoption will depend on complication data, hospital economics and proof that design changes produce meaningful patient benefits.